Magna Carta for individuals living with mental illness.


Journal

International review of psychiatry (Abingdon, England)
ISSN: 1369-1627
Titre abrégé: Int Rev Psychiatry
Pays: England
ID NLM: 8918131

Informations de publication

Date de publication:
Historique:
pubmed: 7 5 2020
medline: 21 10 2021
entrez: 7 5 2020
Statut: ppublish

Résumé

There is considerable evidence to suggest that individuals with mental illness as well as their carers and families are discriminated against across a number of domains. It is also well recognized that people with mental illness are likely to die younger than their counterparts who do not have mental illness. We propose that a Magna Carta is urgently needed to protect the rights of people with mental illness and help reduce discrimination. In this paper a background and rationale for this is offered alongside suggestions for reducing discrimination. The simple message is this; progress in health, economic, environmental and global development will not be made without improvements in mental health. The reasons are equally straightforward as mental illnesses cause more disability than any other health condition and bring enormous pain and suffering to individuals, their families and communities. These impacts lead to early death, damage to the economy and restrain individual progress. Every country needs to take urgent responsibility for defending the rights of individuals with mental illness.

Identifiants

pubmed: 32374191
doi: 10.1080/09540261.2020.1753963
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

75-80

Auteurs

Albert Persaud (A)

The Centre for Applied Research and Evaluation-International Foundation (CAREIF), Centre for Psychiatry, Barts and The London Queen Mary's School of Medicine and Dentistry, London, UK.

Dinesh Bhugra (D)

Department of Affective Disorders, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Preety Das (P)

South London and Maudsley NHS Foundation Trust, London, UK.

Sam Gnanapragasam (S)

South London and Maudsley NHS Foundation Trust, London, UK.

Cameron Watson (C)

Barts Health NHS Trust, London, UK.

Rajiv Wijesuriya (R)

GP trainee, London, UK.

Tom Brice (T)

Foundation Trainee, Cardiff, UK.

Elliot Clissold (E)

Barts Health NHS Trust, London, UK.

João Mauricio Castaldelli-Maia (JM)

Department of Neuroscience, ABC Health University Center, Santo André, SP, Brazil.

Koravangattu Valsraj (K)

South London and Maudsley NHS Foundation Trust, London, UK.

Julio Torales (J)

Department of Psychiatry, School of Medical Sciences, National University of Asunción, San Lorenzo, Paraguay.

Antonio Ventriglio (A)

Department of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH